Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potency
- 1 August 2017
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (16) , 3833-3839
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral AnticoagulantsCardiovascular Drugs and Therapy, 2016
- How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillationAnnals of Hematology, 2015
- New Oral Anticoagulants in Coronary Artery DiseaseCardiovascular & Hematological Disorders-Drug Targets, 2015
- Direct Oral AnticoagulantsJACC: Cardiovascular Interventions, 2014
- Factor XI as a target for antithrombotic therapyDrug Discovery Today, 2014
- New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysisEuropean Heart Journal, 2013
- Factor XI and XII as antithrombotic targetsCurrent Opinion in Hematology, 2011
- Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosisThrombosis and Haemostasis, 2011
- Reduced incidence of ischemic stroke in patients with severe factor XI deficiencyBlood, 2008
- Design, Synthesis, and Biological Evaluation of Peptidomimetic Inhibitors of Factor XIa as Novel AnticoagulantsJournal of Medicinal Chemistry, 2006